Abstract Previously, it was reported that caffeic acid esters inhibit the growth of bloodstream forms of Trypanosoma brucei and the activity of its major lysosomal cathepsin L-like cysteine protease, TbCATL. However, whether this trypanocidal activity is due to inactivation of TbCATL has not so far been demonstrated. Caffeic acid isopentyl ester (isopentyl caffeate) displayed antitrypanosomal activity against T. brucei bloodstream forms with minimum inhibitory concentration (MIC) and 50 % growth inhibition (GI 50 ) values of 1 and 0.31 μg/ml, respectively. The ester also inhibited the activity of purified TbCATL but with a 27-fold higher half maximal inhibitory concentration (IC 50 ) value of 8.5 μg/ml compared to its GI 50 value. In contrast to previous suggestion, isopentyl caffeate did not interact with the active site of TbCATL but inhibited the enzyme in a non-competitive way. In addition, the ester was ineffective in blocking the proteolysis in the lysosome of the parasite, which, however, is a hallmark for inhibitors whose trypanocidal action is through inactivation of TbCATL. These results suggest that the antitrypanosomal activity of isopentyl caffeate (and probably of other caffeic acid esters) cannot be attributed to inhibition of TbCATL. Nevertheless, caffeic acid esters are interesting compounds with promising antitrypanosomal activity. This is supported by a more than 100 times less sensitivity of human HL-60 cells to isopentyl caffeate indicating that the ester has a favourable selectivity profile.
Introduction
African trypanosomes are the causative agents of sleeping sickness in humans and nagana disease in animals. These protozoan parasites belong to the Salivarian group of the genus Trypanosoma that are transmitted by the bite of infected tsetse flies (Glossina sp.) and live and multiply in the blood and tissue fluids of their mammalian host. Sleeping sickness and nagana disease occur in sub-Saharan Africa in an area of 8 million km 2 between the latitudes 14°north and 20°south (Molyneux et al. 1996) . Millions of people and cattle living in this so-called tsetse belt are at risk of getting infected with trypanosomes (World Health Organization 2005 . Both diseases have long caused major health and socio-economic problems in the affected African countries. This is mainly due to the fact that only inadequate chemotherapies are available for treatment of the diseases. All drugs currently used for treatment of sleeping sickness and nagana disease are outdated, require parenteral administration, induce significant toxic side effects, have limited efficacy and are being increasingly subject to drug resistance (Matovu et al. 2001; Fairlamb 2003; Delespaux and de Koning 2007) . Hence, there is an urgent need for the development of new, more effective and safer medications for these devastating diseases.
Caffeic acid esters (3,4-dihydroxycinnamic acid esters) display in vitro activities against bloodstream forms of Trypanosoma brucei (Otoguro et al. 2012 ). In addition, hydroxycinnamic acid esters inhibit the major lysosomal cathepsin L-like protease of T. brucei, TbCATL (aka brucipain or rhodesain), with half maximal inhibitory concentration (IC 50 ) values in the mid-micromolar range (Ogungbe et al. 2010) . TbCATL is a chemical validated drug target in bloodstream forms of T. brucei (Steverding et al. 2012a ). The protease is involved in the degradation of endocytosed host proteins (Steverding et al. 1995; Scory et al. 1999) and is essential to the survival of T. brucei (Steverding et al. 2012a) . In addition, targeting these cysteine proteases with small-molecule inhibitors is trypanocidal both in vitro and in vivo (Scory et al. 1999; Troeberg et al. 1999; Caffrey et al. 2000; Nkemgu et al. 2003; Vicik et al. 2006; 2012a) . However, whether the trypanocidal action of caffeic acid esters is due to inhibition of TbCATL has not so far been shown. In this study, we investigated the trypanocidal activity of isopentyl caffeate and show that the antitrypanosomal action of the ester does not correlate with the inactivation of TbCATL in bloodstream forms of T. brucei. In addition, the ester inhibits TbCATL in a non-competitive way.
Material and methods

Reagents
Human liver cathepsin L (hCATL), caffeic acid (≥99 %, HPLC), ferulic acid (>98.5 %, GC), suramin sodium salt (purity ≥99 %, TLC) and resazurin sodium salt were purchased from Sigma-Aldrich (Dorset, UK). Benzyloxycarbonylphenylalanyl-arginyl-7-amido-4-methyl coumarin (Z-FR-AMC) was bought from BIOMOL (Exeter, UK). Benzyloxycarbonyl-phenylalanyl-arginyl-diazomethyl ketone (Z-FA-DMK) was purchased from Bachem (Weil am Rhein, Germany).
Synthesis of isopentyl caffeate
Caffeic acid (0.5 g, 2.77 mmol) was dissolved in dry isoamyl alcohol (20 ml), and 0.5 ml 96 % (v/v) H 2 SO 4 was added. The reaction mixture was refluxed for 3 h. After cooling to room temperature, the solution was diluted with 100 ml ethyl acetate and washed with 5 % (w/v) NaHCO 3 solution until neutral pH. The organic layer was then washed with distilled water and dried over anhydrous Na 2 SO 4 , and the solvent was removed under vacuum. Isopentyl caffeate (339 mg, 49 % yield) was obtained after silica gel column chromatography (1:1 ethyl acetate/hexane). 
13
C NMR (50 MHz, DMSO-d 6 ) is as follows: δ (ppm) 166.6, 148.4, 145.6, 145.0, 125.5, 121.4, 115.8, 114.8, 62.2, 37.1, 24.7, 22.4 . IR (KBr) (cm ) 3487, 3318, 2959 3487, 3318, , 2924 3487, 3318, , 2907 3487, 3318, , 2868 3487, 3318, , 1682 3487, 3318, , 1636 3487, 3318, , 1602 3487, 3318, , 1535 3487, 3318, , 1462 3487, 3318, , 1443 3487, 3318, , 1395 3487, 3318, , 1394 3487, 3318, , 1304 3487, 3318, , 1279 3487, 3318, , 1240 3487, 3318, , 1184 3487, 3318, , 1171 3487, 3318, , 1122 3487, 3318, , 1103 3487, 3318, , 1049 3487, 3318, , 975, 943, 849, 810 (Sanderson et al. 2013 . Purity: is >96 % ( 1 H NMR and TLC).
Synthesis of ethyl ferulate
To a solution of ferulic acid (0.25 g, 1.29 mmol) dissolved in 25 ml of ethanol, 0.4 ml of 96 % (v/v) H 2 SO 4 was added under stirring and the reaction mixture was refluxed for 3 h. Half of the ethanol was removed under reduced pressure, and the solution was then diluted with 20 ml water and the product extracted with ethyl acetate. The extract was successively washed with 5 % (w/v) NaHCO 3 and water, dried over anhydrous Na 2 SO 4 and filtered, and the solvent was removed under vacuum. Ethyl ferulate was obtained as a brown oil (0.179 mg, 62.48 % yield). 
13
C NMR (50 MHz, CDCl 3 ) is as follows: δ (ppm) 167.5, 148.0, 146.9, 144.8, 127.0, 123.0, 115.6, 114.8, 109.6, 109.4, 60.5, 55.9, 14.4 . IR (KBr) (cm
) 3408, 2980 3408, , 2937 3408, , 1707 3408, , 1631 3408, , 1591 3408, , 1516 3408, , 1435 3408, , 1269 3408, , 1176 3408, , 1033 3408, , 979 (Vafiadi et al. 2005 . Purity is >93 % ( 1 H NMR and TLC).
Cells cultures
Bloodstream forms of T. brucei (clone 427-221a) (Hirumi et al. 1980 ) and human myeloid leukaemia HL-60 cells (Collins et al. 1977) were grown in Baltz medium (Baltz et al. 1985) and RPMI medium (Moore et al. 1967) , respectively. Both culture media were supplemented with 16.7 % (v/v) heat-inactivated foetal calf serum. All cultures were maintained in a humidified atmosphere containing 5 % CO 2 at 37°C.
Toxicity assays
Toxicity assays were carried out as previously described (Merschjohann et al. 2001) . In brief, cells (trypanosomes and HL-60 cells) were seeded in 96-well plates in a final volume of 200 μl of the appropriate medium containing various concentrations of hydroxycinnamate derivatives (10-fold dilution from 100 μg/ml to 1 ng/ml) and 1 % DMSO. Wells just containing medium and 1 % DMSO served as controls. The initial cell densities were 1 × 10 4 /ml for trypanosomes and 1 × 10 5 /ml for HL-60 cells. After a 24-h incubation, 20 μl of a 111-μg/ml resazurin solution prepared in PBS was added and the cells were incubated for a further 48 h. Thereafter, the plates were read on a microplate reader using a test wavelength of 570 nm and a reference wavelength of 630 nm. The 50 % growth inhibition (GI 50 ) value, i.e., the concentration of a compound necessary to reduce the growth rate of cells by 50 % compared to the control, was determined by linear interpolation (Huber and Koella 1993) . The minimum inhibitory concentration (MIC) values, i.e., the concentration of the drug at which all trypanosome and human cells were killed, was determined microscopically.
Determination of IC 50
For determination of the IC 50 , purified TbCATL and hCATL were assayed with 5 μM of the fluorogenic substrate Z-FR-AMC in a measuring buffer (100 mM citrate, pH 5.0, 2 mM DTT) containing different concentrations of isopentyl caffeate (2-fold dilutions from 40 to 1.25 μg/ml) and 1.5 % DMSO. Controls contained 1.5 % DMSO alone. The final enzyme concentrations in the assays were 34 ng/ml for TbCATL and 18 ng/ml for hCATL. After a 10-min incubation at room temperature, the reaction was stopped by adding the alkylating agent iodoacetic acid to a final concentration of 5 mM. Release of free 7-amino-4-methylcoumarin (AMC) was measured at excitation and emission wavelengths of 360 and 460 nm in a Bio-Rad VersaFluor fluorometer. IC 50 values were determined by linear interpolation (Huber and Koella 1993) .
Determination of inhibitor type and K i
The inhibitor type of isopentyl caffeate was determined by kinetic analysis. Purified TbCATL was incubated with varying concentrations of Z-FR-AMC (0.25, 0.5 and 1 μM) and isopentyl caffeate (0, 10, 20 and 30 μg/ml) in a measuring buffer containing 2 % DMSO. The final concentration of TbCATL in the assay was 34 ng/ml. The release of free AMC was recorded as described above every 30 s for 5 min. The velocity of the reaction (relative fluorescence units (RFUs)/min) was calculated by linear interpolation of the data. The inhibitor type and the K i value were graphically determined by Lineweaver-Burk plot and Dixon plot, respectively.
Flow cytometry
Bloodstream forms of T. brucei (1.5 × 10 7 /ml) were incubated with 50 μg/ml fluorescein-labelled bovine transferrin in Baltz medium supplemented with 2 % BSA and 100 μM isopentyl caffeate in the presence of 1 % DMSO. Control cultures were treated with 1 % DMSO alone (negative control) or with 100 μM Z-FA-DMK (positive control). After 2 h of incubation, cells were washed three times with PBS/1 % glucose and fixed with 2 % formaldehyde/0.05 % glutaraldehyde in PBS, and fluorescence was quantified with a CyFlow® Cube 6 flow cytometer. Gates were set to exclude cell fragments and debris from the analysis, and 100,000 gated cells were analysed.
Results and discussion
First, we evaluated the trypanocidal and cytotoxic activity of isopentyl caffeate (3,4-dihydroxycinnamic acid isopentyl ester, Fig. 1) . The ester showed a dose-dependent inhibitory effect on the growth of T. brucei bloodstream forms in cell cultures with an MIC value of 1 μg/ml (4 μM) and a GI 50 value of 0.31 μg/ml (1.24 μM) (Fig. 2) . This finding confirms previous observation that caffeic acid esters display antitrypanosomal activities, although their efficacy was shown to be dependent on the nature of the ester side chain (Otoguro et al. 2012) . However, esterification is essential for activity, as the unesterified parent compound, caffeic acid (3,4-dihydroxycinnamic acid, Fig. 1 ), was 100-to 350-fold less trypanocidal with an MIC value of 100 μg/ml (555 μM) and a GI 50 value of 79 μg/ml (438 μM) (Fig. 2) . Similarly, ethyl ferulate (3-methoxy-4-hydroxycinnamic acid ethyl ester, Fig. 1 substantially reduced trypanocidal activity (MIC = 100 μg/ml (450 μM); GI 50 = 24.5 μg/ml (110 μM)) (Fig. 2) . This observation indicates that the presence of two hydrogen-bond donors in the aromatic moiety is crucial for the trypanocidal activity of hydroxycinnamic acid ester derivatives. The cytotoxicity of isopentyl caffeate towards human HL-60 cells was found to be low with an MIC value of 100 μg/ml (400 μM) and a GI 50 value of 44 μg/ml (176 μM) (Fig. 2) . Thus, the selectivity (ratio of cytotoxicity to trypanocidal activity) of the ester was promising with an MIC ratio of 100 and a GI 50 ratio of 142. Next, we investigated the inhibitory activity of isopentyl caffeate against purified TbCATL and hCATL. The ester inhibited the activity of both enzymes in a very similar dosedependent manner (Fig. 3) . The calculated IC 50 values for the trypanosome and the human enzyme were 8.5 ± 0.8 μg/ml (34 μM) and 10.4 ± 2.2 μg/ml (42 μM), respectively, which were not statistically significantly different from each other (Student's t test; p = 0.24). Similar inhibitory concentrations were previously reported for bornyl caffeate for both proteases, although the human enzyme was found to be 2.5-fold more sensitive to this ester than the trypanosome enzyme (Ogungbe et al. 2010) . The much higher IC 50 value of isopentyl caffeate for TbCATL compared to its GI 50 value for inhibition of trypanosome growth (8.5 vs 0.31 μg/ml) suggests that the trypanocidal activity of the ester is most likely due to an off-target effect. Alternatively, it is also possible that isopentyl caffeate is metabolised to a more active compound within the parasites. This has recently been shown for the cysteine protease inhibitor CA-074/CA-074Me (Steverding et al. 2012a) .
So far, all cysteine protease inhibitors whose trypanocidal activity was shown to be the result of inactivation of TbCATL were exclusively irreversible inhibitors (Steverding et al. 2012a) . Although, based on molecular docking analysis with bornyl caffeate in TbCATL and hCATL, it was previously suggested that caffeic esters may bind to the active site of the proteases (Ogungbe et al. 2010) , the mechanism of inhibition has not been experimentally determined. In addition, acrylic acid esters (note that caffeic acid is 3,4-dihydroxybenzeneacrylic acid) have so far not been described as irreversible inhibitors of cysteine proteases (Otto and Schirmeister 1997; Lecaille et al. 2002; Steverding et al. 2006) . In fact, preliminary inhibition studies indicated that isopentyl caffeate is a reversible inhibitor of TbCATL (data not shown). To establish the inhibitory type of isopentyl caffeate, kinetic studies of the inhibition reaction were carried out with purified TbCATL. Double reciprocal (Lineweaver-Burk plot) analysis gave a family of lines with increasing slopes as the isopentyl caffeate concentration increased (Fig. 4a) . These data indicated a non-competitive inhibition mechanism of the ester as the lines converged to the same point on the x-axis. Plotting the reciprocal velocity (1/v) against the inhibitor concentration (Dixon plot) confirmed this finding since the lines drawn for each substrate concentration met again in a single point on the x-axis (Fig. 4b) . From the point of intersection, the inhibitor constant K i for isopentyl caffeate was determined to be 10.0 ± 0.9 μg/ml. This was not statistically significantly when compared to the IC 50 value of 8.5 ± 0.8 μg/ml (Student's t test; p = 0.10). The finding that K i is not different from the IC 50 is a characteristic feature of noncompetitive inhibitors (Brandt et al. 1987) .
To test whether the trypanocidal effect of isopentyl caffeate was the result of inactivation of TbCATL, uptake experiments with fluorescein-labelled transferrin were carried out. It is well established that blockage of TbCATL leads to accumulation of transferrin in the lysosome of bloodstream forms of T. brucei (Grab et al. 1992; Steverding et al. 1995; Scory et al. 1999) and that this accumulation can be easily quantified by flow cytometry (Steverding et al. 2012a (Steverding et al. , 2012b . However, trypanosomes incubated with 100 μM isopentyl caffeate (25 μg/ml; a concentration which was 25 times the MIC value (see above)) accumulated much less transferrin (16 % based on the median of the fluorescence intensity signal) as those incubated with 100 μM Z-FA-DMK (positive control) (Fig. 5) , a well-established inhibitor of TbCATL with trypanocidal activity (Scory et al. 1999 ). In addition, this accumulation was only three percentage points more than that of negative cells incubated with DMSO (13 %). It was previously shown that only those inhibitors kill trypanosomes through inhibition of TbCATL that completely inactivate the protease following accumulation of transferrin in the lysosome (Steverding et al. 2012a ).
Conclusion
Although isopentyl caffeate is an inhibitor of TbCATL, its trypanocidal activity cannot be attributed to inhibition of this cysteine protease. This is evident from the following findings. First, isopentyl caffeate was determined to be a noncompetitive inhibitor of TbCATL. However, non-competitive inhibitors usually do not completely inactivate their target enzymes, but this was previously shown to be necessary if trypanosomes are to be killed through inhibition of TbCATL (Steverding et al. 2012a ). Second, incubation of trypanosomes with lethal concentration of isopentyl caffeate did not lead to a significant accumulation of fluorescent transferrin in the lysosome. However, only cysteine protease inhibitors that cause substantial lysosomal accumulation of transferrin will kill trypanosomes through blocking of TbCATL (Steverding et al. 2012a ). Third, isopentyl caffeate was much more effective in inhibiting the growth of trypanosomes than the activity of TbCATL. Usually, small molecule inhibitors show reduced activity in cell-based assays compared to biochemical assays and not vice versa (An and Tolliday 2010) . On the other hand, isopentyl caffeate was shown to display promising antitrypanosomal activity. In fact, the compound nearly meets the activity and cytotoxicity criteria for drug candidates for African trypanosomiasis (GI 50 <0.2 μg/ml; selectivity >100) (Nwaka and Hudson 2006) . In addition, it should be easy to improve the trypanocidal activity of caffeic acid esters through structural modification. In particular, long alkyl and aryl containing side chains seem to provide potent antitrypanosomal activity (Otoguro et al. 2012) . Ring substituents may be another possibility to increase the trypanocidal activity. For example, adding a third hydroxyl group to give either 2,3,4-trihydroxy or 3,4,5-trihydroxy derivatives has previously been shown to increase the inhibitory activity against HIV-1 integrase (Burke et al. 1995) .
